Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

Recruiting

Phase 1

RAD301Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

Sponsor:

Radiopharm Theranostics, Ltd

Code:

NCT05799274

Conditions

Healthy Volunteers

Pancreatic Ductal Adenocarcinoma

Non-small Cell Lung Cancer (NSCLC)

Esophageal Squamous Cell Carcinoma

Cervical Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

RAD301 ([68Ga]-RAD301)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-24. This information was provided to ClinicalTrials.gov by Radiopharm Theranostics, Ltd on 2026-07-17.